1. Home
  2. RES vs NTLA Comparison

RES vs NTLA Comparison

Compare RES & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RES
  • NTLA
  • Stock Information
  • Founded
  • RES 1984
  • NTLA 2014
  • Country
  • RES United States
  • NTLA United States
  • Employees
  • RES N/A
  • NTLA N/A
  • Industry
  • RES Oilfield Services/Equipment
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • RES Energy
  • NTLA Health Care
  • Exchange
  • RES Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • RES 1.1B
  • NTLA 1.2B
  • IPO Year
  • RES N/A
  • NTLA 2016
  • Fundamental
  • Price
  • RES $4.63
  • NTLA $11.82
  • Analyst Decision
  • RES Hold
  • NTLA Buy
  • Analyst Count
  • RES 4
  • NTLA 19
  • Target Price
  • RES $4.94
  • NTLA $35.11
  • AVG Volume (30 Days)
  • RES 2.0M
  • NTLA 4.6M
  • Earning Date
  • RES 07-24-2025
  • NTLA 08-11-2025
  • Dividend Yield
  • RES 3.37%
  • NTLA N/A
  • EPS Growth
  • RES N/A
  • NTLA N/A
  • EPS
  • RES 0.25
  • NTLA N/A
  • Revenue
  • RES $1,426,699,000.00
  • NTLA $45,569,000.00
  • Revenue This Year
  • RES $16.11
  • NTLA N/A
  • Revenue Next Year
  • RES $10.71
  • NTLA N/A
  • P/E Ratio
  • RES $18.99
  • NTLA N/A
  • Revenue Growth
  • RES N/A
  • NTLA N/A
  • 52 Week Low
  • RES $4.10
  • NTLA $5.90
  • 52 Week High
  • RES $7.54
  • NTLA $27.28
  • Technical
  • Relative Strength Index (RSI)
  • RES 45.83
  • NTLA 54.03
  • Support Level
  • RES $4.39
  • NTLA $12.48
  • Resistance Level
  • RES $5.00
  • NTLA $13.73
  • Average True Range (ATR)
  • RES 0.18
  • NTLA 0.88
  • MACD
  • RES -0.01
  • NTLA -0.14
  • Stochastic Oscillator
  • RES 52.86
  • NTLA 26.78

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: